1. Risk of toxicity versus risk of death: A complex equation in the management of highly curable malignancies

   • Maurie Markman

   Editor’s Commentary 16 October 2008 Pages: 359 - 360

2. Consolidation and maintenance rituximab therapy in chronic lymphocytic leukemia

   • Nicole Lamanna
   • Mark A. Weiss

   Clinical Trials Report 16 October 2008 Pages: 363 - 364

3. Modern approaches to treating chronic myelogenous leukemia

   • Javier Pinilla-Ibarz
   • Celeste Bello

   OriginalPaper 16 October 2008 Pages: 365 - 371

4. Myelodysplastic syndrome: An update on diagnosis and therapy

   • Ahrin Koppel
   • Gary Schiller

   OriginalPaper 16 October 2008 Pages: 372 - 378

5. Treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

   • Ryuzo Ohno

   OriginalPaper 16 October 2008 Pages: 379 - 387

6. Do six or eight cycles work better with CHOP-14 and rituximab?

   • Paul A. Hamlin

   Clinical Trials Report 16 October 2008 Pages: 391 - 392

7. Management of relapsed diffuse large B-cell lymphoma

   • Vaishalee Padgaonkar Kenkre
   • Sonali M. Smith

   OriginalPaper 16 October 2008 Pages: 393 - 403

8. Novel therapies in peripheral T-cell lymphomas

   • Hilary M. O’Leary
   • Kerry J. Savage

   OriginalPaper 16 October 2008 Pages: 404 - 411

9. Treatment of diffuse large B-cell lymphoma in the elderly: Strategies integrating oncogeriatric themes

   • Pieternella J. Lugtenburg
   • Pieter Sonneveld

   OriginalPaper 16 October 2008 Pages: 412 - 419

10. Beyond rituximab: The future of monoclonal antibodies in B-cell non-Hodgkin lymphoma

    • Manzurul A. Sikder
    • Jonathan W. Friedberg

    OriginalPaper 16 October 2008 Pages: 420 - 426

11. Clinical trials report

    • Kim A. Margolin

    Report 16 October 2008 Pages: 429 - 430

12. The biology and management of uveal melanoma

    • Takami Sato
    • Fei Han
    • Akira Yamamoto

    OriginalPaper 16 October 2008 Pages: 431 - 438

13. Melanoma and the tumor microenvironment

    • Jessie Villanueva
    • Meenhard Herlyn

    OriginalPaper 16 October 2008 Pages: 439 - 446